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Summary. We report the case of a 4-years-old boy who was admitted with hypovolemic shock due to a 
severe gastrointestinal bleeding. The esophagogastroduodenoscopy (EGDS) showed hiatus hernia, ero-
sions and ulcerations of the lower esophagus, possibly due to a gastroesophageal reflux, and a small 
duodenal erosion. The child was previously healthy and he had never shown any symptoms related to this 
condition. The only product taken by the child in the previous days was a syrup containing several herbs, 
among which Filipendula ulmaria (L.) Maxim. and Salix spp. (known to contain salicylates), marketed 
as food and prescribed by his paediatrician to treat a mild cold accompanied by fever. Quali-quantitative 
analysis confirmed the presence of salicylates in the syrup. Naranjo algorithm showed a probable cor-
relation between the onset of symptoms and the consumption of the herbal remedy. The child recovered 
after receiving intensive care. The product was withdrawn from Italian market. 
Key words: medicine, herbal, complementary therapies, phytotherapy, salicylates, adverse effects, gastrointestinal 
hemorrhage.
 
Riassunto (Shock ipovolemico dovuto ad un grave sanguinamento gastrointestinale in un bambino che aveva 
assunto uno sciroppo a base di erbe). Segnaliamo il caso di un bambino di 4 anni giunto in ospedale con un 
quadro di shock ipovolemico a causa di un grave sanguinamento gastrointestinale. L’esofagogastroduod
enoscopia (EGDS) mostrava un’ernia iatale, erosioni ed ulcerazioni dell'esofago inferiore, probabilmente 
a causa di un reflusso gastroesofageo, ed una piccola erosione duodenale. Il bambino, precedentemente in 
buona salute, non aveva mai mostrato alcun sintomo correlato a questa condizione. L’unico prodotto as-
sunto dal paziente nei giorni precedenti era uno sciroppo a base d’erbe, tra le quali Filipendula ulmaria (L.) 
Maxim. e Salix spp. (specie note per contenere salicilati), commercializzato come alimento e prescritto dal 
suo pediatra per curare una live sintomatologia da raffreddamento con febbre. L’analisi quali-quantitativa 
confermava la presenza di salicilati nello sciroppo. L’algoritmo di Naranjo mostrava una correlazione pro-
babile tra l'esordio dei sintomi e l’assunzione del prodotto. Il bambino, si è rapidamente ristabilito senza 
sequele dopo essere stato sottoposto a cure intensive. Il prodotto è stato ritirato dal mercato italiano.
Parole chiave: fitoterapia, salicilati, effetti avversi, emorragia gastrointestinale, terapie complementari, medicina 
naturale.
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INTRODUCTION
Widespread opinion that natural remedies are com-
pletely harmless lead parents to use them instead of 
conventional drugs to treat their children diseases [1-4]. 
Nevertheless, safe and confident use of herbal supple-
ments is an issue gaining more and more attention as 
they can lead to mild-to-severe adverse reactions [4, 5].
Moreover, physicians and paediatricians do not 
usually undergo adequate training for prescribing 
Complementary and Alternative Medicines (CAM) 
remedies, evaluating their clinical effects and assist-
ing families in using them wisely [4, 6]. 
The case we report shows the potential harm of 
herbal supplements if  incorrectly used in paediatric 
patients.
CASE REPORT 
A 4-years-old boy weighting 17 kg was admitted to 
the hospital for sudden gastrointestinal bleeding lead-
ing to hypovolemic shock. The day before the child 
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hematemesis during the night. At the admission he 
was drowsy, pale, hypotensive (BP = 60/40 mmHg) and 
anemic (Hb = 6.4 g/dL). Blood test showed RBC (red 
blood cells) 2.4 x 1012/L, MCV (mean cell volume) 
78.4 fL, MCH (mean cell hemoglobin) 26.4 pg/cell, 
MCHC (mean corpuscular hemoglobin concentra-
tion) 33.7 g/dL, Plt (platelets) 280 000 x 109/L, WBC 
(white blood cells) 9.3 x 109/L with normal formula. 
The patient was admitted to the paediatric intensive 
care unit (ICU), where emergency treatment was pro-
vided and stabilization achieved. 
Esophagogastroduodenoscopy (EGDS) showed 
hiatus hernia, erosions and ulcerations of the lower 
esophagus (possibly related to a gastroesophageal re-
flux) and a small duodenal erosion; about 150 ml of 
coagulated blood were removed from the stomach. 
Since the boy had not previously shown any symp-
toms of gastroesophageal reflux, the disease had nev-
er been investigated. 
Two days before the child had shown fever and a 
mild cold likely due to a viral respiratory infection, 
not accompanied by any gastrointestinal manifesta-
tion. 
On the first day of illness a single rectal dose of 
acetaminophen, 250 mg, was administered; the 
next day he was treated with 15 ml (5 ml for three 
times) of an herbal syrup and he started bleeding 
on the night. The syrup, containing ribwort plantain 
(Plantago lanceolata L.), liquorice (Glycyrrhiza glabra 
L.), willow (Salix spp.), black elder (Sambucus nigra 
L.), meadowsweet (Filipendula ulmaria (L.) Maxim.), 
and propolis, was prescribed by his paediatrician and 
never taken before.
No other drugs had been administered in the previ-
ous twenty days, but thirty days before he was treated 
for five days with 285 mg/day of niflumic acid with-
out showing any adverse effects. The herbal product 
was discontinued and the patient recovered.
The case was evaluated according to the Naranjo 
causality algorithm scale [7]. 
The probability determination score was 7, which 
means that the reaction was probably caused by the 
syrup.
 SALICYLATE  
QUALI-QUANTITATIVE ANALYSIS
The herbal remedy was tested for salicylate (salts 
and esters of salicylic acid) content, at first applying 
the colourimetric method reported in the European 
Pharmacopoeia 5th ed. [8]. 
According to this method, the addition of 0.5 ml of 
FeCl3 to 1 ml of Freddobaby syrup produced a highly 
colored (violet) iron (III)-salicylate that persisted af-
ter the addition of 0.1 ml acetic acid, thus confirming 
the presence of salicylic acid in the product. 
High performance liquid chromatography (HPLC) 
qualitative and quantitative analysis was subse-
quently performed. Sample preparation: to the di-
luted syrup (1:1 v/v) in MeOH, 50 μl resorcinol so-
lution as internal standard (5 mg/ml) were added. 
Salicylates were monitored by reversed phase high 
performance liquid chromatography (RP-HPLC). 
Reference standard: salicin, saligenin (salicyl al-
cohol), salicylic acid and methyl salicylate were ob-
tained from Sigma Chemical Co., St. Louis, MO., 
USA. Ethanol reference solution was a pool: salicin 
(0.56 mg/ml) + saligenin (0.86 mg/ml) + salicylic ac-
id (1.33 mg/ml), and methyl salicylate (0.5 ml/ml).
HPLC chromatographic system was a Jasco instru-
ment, equipped with a detector: UV 975 Intelligent 
UV/VIS Detector; Intelligent Fluorescence Detector 
FP-1520; pump PU-980 Intelligent HPLC Pump; in-
jection valve manual, Rheodyne mod. 7725 Catati, 
California; column LC-18 Supelco 150 mm x 4.6 mm 
(i.d.), 5 μm particle size. Eluent A = K3PO4 15 mM 
in H2O: ACN (95:5, v/v) at pH = 3 with concentrat-
ed H3PO4; eluent B = K3PO415 mM in H2O: ACN 
(50:50, v/v) at pH = 3 with concentrated H3PO4. 
Gradient elution: 5 min 100% A, 20 min 50% A, 5 
min 0% A, 10 min isocratic elution 0% A. Flow 0.5 
ml/min, UV detection λ = 303 nm, Fluorescence de-
tection (exc) λ = 299 nm and (em) λ = 409 nm. A 
fixed loop 20 μl was used.
HPLC profiles of the standard solution (Figure 1) 
and of the FreddoBaby syrup (Figure 2) are report-
ed.
The salicylic acid content, the most active sali-
cylate, was determined and quantified by fluorim-
etry in acidic solution where efficient fluorescence of 
this compound is usually observed. This method can 
be of significant importance in the determination of 
the extent of hydrolysis of salicylate. Fluorescence-
based quantitation is more sensitive than that ob-
tained with the UV test and it is specific for the com-
pound of interest (i.e. salicylic acid).
The quantitative analysis of salicylates, performed 
according to the internal standard method, revealed 
0.4 mg/ml of salts and esters of salicylic acid (ex-
pressed as salicin, salicylic acid, salicyl alcohol and 
esters of salicylic acid, and their methylated deriva-
tives) in the FreddoBaby syrup. The HPLC results 
well correlate with the colourimetric reaction by 
means of ferric chloride.
DISCUSSION
The product label reported the name but no the 
percentage content of the ingredients; technical data 
sheet was achieved but titration of active extract was 
not available. 
MEDLINE, EMBASE and MICROMEDEX searches 
were performed to find articles related to gastrointestinal 
bleeding associated to Plantago lanceolata, Glycyrrhiza 
glabra, Salix spp., Sambucus nigra, Filipendula ulmaria, 
propolis, salicylates, niflumic acid and acetaminophen 
internal use.
No reports of gastric damage related to use of Plantago 
lanceolata, Sambucus nigra, and propolis were found.
Some studies showed a possible anti-inflammatory 
and anti-ulcer action of Glycyrrhiza glabra and its 
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extracts [9, 10]; on the other hand, licorice root is 
thought to contain coumarins or coumarin deriva-
tives that demonstrated antiplatelet activity in vitro 
[11]. Therefore, it may theoretically increase the risk 
of bleeding especially if  taken with antiplatelet drug 
[12]. Nevertheless, it is really difficult to ascertain 
pharmacological interactions between licorice and 
salicylates or other components of the herbal rem-
edy, while it is unlikely any interaction with aceta-
minophen due to the short half-life of this drug [13] 
and the time elapsed (20 hours) between the sup-
pository administration and the consumption of 
the syrup. 
Surprisingly, one case of gastrointestinal bleeding re-
lated to Filipendula ulmaria and Salix spp. in a dog that 
ate a dietary supplement containing both the plants 
[14] was described; although this was a veterinary re-
port, the progression of the illness and the clinical pic-
ture closely resembles the event we observed.
Filipendula ulmaria (L.) Maxim. (Fam. Rosaceae) 
and Salix spp. (Fam. Salicaceae) are known to con-
tain various salicylates. In particular, Meadowsweet 
contains a minimum of 0.1% v/w of steam-volatile 
substances (dried drug), among which gaultherin 
(glycoside of methyl salicylate); Salix contains not 
less than 1.5% of salicylic derivatives, mainly as sal-
icin (an alcoholic beta-glucoside) [15-18]. 
In vitro, it is possible to obtain the hydrolysis of salicin 
by alkaline saponification according to the European 
Pharmacopoeia 6th ed. or by means of enzymatic re-
action, according to Association of Agricultural 
Chemists (AOAC) International [19]. The result of 
the hydrolysis is the loss of the glucose moiety and the 
discharge of the alcoholic genin saligenin (phenolic 
alcohol called also salicyl alcohol). In vivo pharmaco-
logical studies in rats indicate that salicin acts as a pro-
drug which is transformed into its active metabolite, 
salicylic acid, via saligenin formation [20, 21]. Both 
gaultherin and salicin are supposed to have less gastric 
ulcerogenic effect compared to aspirin [22, 23]. 
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Fig. 1 | HPLC profile of the salicylate 
standard solution.
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the addition of ferric chloride revealed the presence 
of free salicylates in the syrup. The quali-quantita-
tive analysis confirmed the presence of methyl sali-
cylic and salicylic acid derived by hydrolysis of natu-
ral occurring glycoside compounds (Figure 2).
This spontaneous hydrolysis reaction shows up 
that pharmacological activity of multiple ingredi-
ents natural preparations may be unpredictable and 
should be assessed by testing the final product. 
Methyl salicylic and salicylic acid are not intended 
for oral consumption because of their irritative ac-
tion on the mucosae and for their high salicylate 
potency (which is almost 1.4 times the potency of 
acetylsalicylic acid) [24]. 
Salicylates are strong analgesic and antipyretic de-
rivatives of salicylic acid often prescribed or used as 
self-medication to relieve fever and mild pain, espe-
cially headache and arthromyalgia; although these 
compounds are OTC drugs, they can be used in chil-
dren only under medical prescription. 
Salicylates have often been implicated in the devel-
opment of gastrointestinal damages [2, 13, 25]. 
Their gastrointestinal toxicity can be ascribed to 
two distinct mechanisms:
a)  indirect action: salicylates act mainly by inhibit-
ing the enzyme prostaglandin endoperoxide syn-
thase (or cyclooxygenase or COX), which exists 
in two isoforms (COX1, constitutive, and COX2, 
induced during inflammation) and converts ara-
chidonic acid to several prostanoids. The unspe-
cific inhibition of both COX1 and COX2 results 
in attenuation of pain, fever and other symptoms 
of inflammation (mediated by the prostaglandins 
produced by COX2), and in weakening of several 
defensive mechanisms in the tissues that express 
COX1 (including the gastrointestinal tract) [13]; 
b)  direct action: most salicylates, when ingested, in-
crease by topic contact the gastric mucosa per-
meability to hydrogen ions, mainly by reducing 
its hydrophobicity; this leads to an inflammatory 
response that enhances the epithelial damage 
[13, 26-29 ]. 
According to the literature, upper gastrointestinal 
complications associated with several NSAIDs in 
children can be expected; in particular, several cases 
of gastrointestinal bleeding, both in adults and chil-
dren, related to the administration of salicylates are 
reported [2, 25, 26]. 
 On the other hand, only mild effects but no seri-
ous events (hemorrhage, hypovolemic shock) con-
nected to the use of niflumic acid are described [30] 
and there is a general agreement about the safety of 
therapeutic doses of acetaminophen compared to 
aspirin and other NSAIDs [31, 32] unless it is taken 
at high doses together with other analgesic/antipy-
retic agents [33, 34]. 
In the present case, the child took about 15ml of 
the herbal syrup, containing 0.4 mg/ml of salicylates, 
corresponding to a total dose of 6 mg (0.35 mg/kg), 
an amount far from being a toxic dose. 
It is not clear whether the reaction observed result-
ed from the exacerbation of an existing pathology 
or was the first manifestation of a disease just devel-
oped, but several factors suggest that the symptoms 
were probably caused by the herbal remedy.
The child was previously healthy, and had already 
taken both acetaminophen and niflumic acid in the 
past without any side effects; moreover, the time 
elapsed between the last administration of niflumic 
acid and the accident makes the correlation unlikely, 
while there is a close temporal association between 
the consumption of the syrup and the onset of the 
symptoms. Naranjo score confirmed this hypoth-
esis.
Besides causing gastrointestinal injuries, salicylates 
have been reported to cause allergic reactions (in some 
cases even anaphylaxis) in sensitive subjects [35, 36]. 
Furthermore, they are suspected to act as co-fac-
tors in the development of Reye’s syndrome (acute 
non inflammatory encephalopathy accompanied 
by selective hepatic abnormalities and metabolic 
decompensation) in children affected by viral infec-
tions [1, 37, 38]; for this reason, starting from 1986 
several alerts were issued against the use of sali-
cylates-containing medications in children and teen-
agers affected by or recovering from chicken pox or 
flu, and mandatory warning labels were instituted in 
many countries [1, 37-40]. 
Apart from medical and pharmacological consid-
erations, it seems important to highlight some other 
aspects of this event.
The syrup involved in our case was marketed as 
“food”, therefore, according to the European law 
(89/395/CEE, 2000/13/CE), it should have been 
free from any therapeutic activity; for this reason 
its label reported all the constituents but not their 
active principles (salicylates were not mentioned) 
and it did not undergo the notification procedure 
that is mandatory for supplements. Nevertheless, 
its name (“FreddoBaby” in Italian; literally trans-
lated “ColdBaby” into English) suggested that the 
syrup could be useful in the treatment of cold states 
in children and it could be bought without medical 
prescription.
On the other hand, the remedy was prescribed by a 
paediatrician, unaware of pharmacological proper-
ties of herbal ingredients and of possible presence 
of salicylates. 
This explains why our patient was treated with this 
remedy despite the known risks connected with the 
use of salicylates in children with febrile illnesses.
The spreading use of  natural remedies is strong-
ly related to the common opinion, frequently 
diffused through the mass media, that they are 
suitable for subjects in any age group and health 
condition because they always are beneficial and 
harmless [41]. 
Our report shows that this misconception can lead 
both common people and health practitioners to 
use carelessly such remedies without regard to any 
possible adverse effects.
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s CONCLUSIONS 
Herbs contain several constituents that may exert 
a pharmacological activity, in the same way as con-
ventional medicines do. Therefore they can not be 
claimed as absolutely safe and free from adverse ef-
fects. Products containing salicylates can be highly 
hazardous if  used by children or aspirin-sensitive 
subjects. Natural remedies should be used under 
the supervision of adequately trained practitioners 
and administered cautiously to paediatric patients, 
unless reliable evidence of their safety is provided. 
Spontaneous reporting can contribute to improve 
knowledge about potential adverse reactions to me-
dicinal plants and increase awareness among health 
personnel and public about their benefit–harm as-
sessment. 
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